Actively Recruiting
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
Led by Hospital Clinic of Barcelona · Updated on 2025-12-09
110
Participants Needed
1
Research Sites
250 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.
CONDITIONS
Official Title
Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women 4 to 9 months postpartum
- Experiencing new pain during vaginal penetration after delivery
- History of obstetric injury
- Provided informed consent
You will not qualify if you...
- Contraindications to radiofrequency such as pacemaker, active infection, or pregnancy
- History of cesarean section
- Dyspareunia before labor
- Previous vulvo-vaginal diseases
- Diagnosed postpartum depression
- History of cancer in the pelvic area
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clinic Barcelona
Barcelona, Spain, 08036
Actively Recruiting
Research Team
C
Carla E Box, PT, Msc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here